Merck 4Q Earnings Plummet

January 29, 2007

Merck & Co. reported Tuesday that fourth-quarter profit plunged 58% despite higher revenues as the drugmaker took a slew of charges for restructuring costs, an acquisition and increased legal reserves, mainly for its withdrawn painkiller Vioxx.

*For more on this story,

read the full Associated Press article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Weekly in-depth coverage in print and digital formats
Special Features: OC's Wealthiest, Top Priced Home Sales, Giving Guide, OC500, Charity Event Guide, Best Places to Work, Indispensables, Largest Charitable Gifts
The annual Book of Lists: Orange County's top companies across every industry

Epicor Sales Surge; Charges Hit Profits

Consumer Confidence Improves in January

staff-author

Merck 4Q Earnings Plummet

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Anduril, General Atomics Win Fighter Drone Contracts

Midday Stock Roundup: TTM Rises 6% on Acquisition Announcement

Octane Launches Mussallem Cardiovascular Accelerator

Related Articles

Anduril, General Atomics Win Fighter Drone Contracts

Midday Stock Roundup: TTM Rises 6% on Acquisition Announcement

Octane Launches Mussallem Cardiovascular Accelerator

The Picklr Indoor Pickleball Coming to Placentia

Intellian Opens New California Manufacturing Campus

Advertise With Us

About Us

Subscriber Links

Other Journals